Halobetasol Propionate Ointment

Product/Composition Halobetasol Propionate Ointment
Strength 0.05%
Form Ointment
Production Capacity 1 Million Ointment / Month
Packaging 15gm, 30gm
Therapeutic use Skin Care, Dermatology
Package Insert/Leaflet Available upon request

Halobetasol Propionate Ointment

Working, Mechanism of Action, and Pharmacology

Halobetasol Propionate Ointment improves the patient’s condition by blocking the production of inflammatory mediators, helping to reduce redness, swelling, and irritation associated with various skin conditions.

Composition and Active Ingredients

Halobetasol Propionate Ointment contains the following active ingredient:

  • Halobetasol Propionate

Side Effects

The following are possible side effects, although they may not occur in every patient. Some may be rare but serious. Consult your doctor if these persist or worsen:

  • Redness of the skin

  • Changes in skin pigmentation

  • Stinging or burning sensation

  • Rash or inflammation of hair follicles

  • Abnormal hair growth

Precautions & How to Use

Before using Halobetasol Propionate Ointment, inform your doctor about:

  • Current medications, including over-the-counter products, vitamins, or herbal supplements

  • Allergies

  • Pre-existing diseases and health conditions, including pregnancy, breastfeeding, or upcoming surgery

Follow your doctor’s instructions or the directions on the product insert. Dosage depends on your condition. Contact your doctor if your condition does not improve or worsens.

Important Counseling Points:

  • Avoid contact with eyes

  • Consult your doctor if you are diabetic, pregnant, breastfeeding, or treating neonates/infants

  • Do not use if allergic to halobetasol

  • Avoid using under occlusive dressings or on large areas of the body unless prescribed

Buy Halobetasol Propionate Ointment

Onco India International is a trusted manufacturer, supplier, and exporter of Halobetasol Propionate Ointment. For genuine products, bulk orders, or distribution inquiries, contact Onco India International directly.